Clinical Trial Update: hATG+CsA vs hATG+CsA+Eltrombopag for SAA [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing horse anti-thymocyte globulin plus cyclosporine with and without eltrombopag for severe aplastic anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• ATGAM (anti-thymocyte globulin (equine))
• CYCLOSPORINE (cyclosporine)
• Eltrombopag (eltrombopag)

Snippet

Sponsor: European Society for Blood and Marrow Transplantation | Conditions: Severe Aplastic Anemia | Phase 3 | Status: COMPLETED